pubmed-article:20010312 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20010312 | lifeskim:mentions | umls-concept:C0021270 | lld:lifeskim |
pubmed-article:20010312 | lifeskim:mentions | umls-concept:C1545588 | lld:lifeskim |
pubmed-article:20010312 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
pubmed-article:20010312 | lifeskim:mentions | umls-concept:C0449943 | lld:lifeskim |
pubmed-article:20010312 | lifeskim:mentions | umls-concept:C0086960 | lld:lifeskim |
pubmed-article:20010312 | lifeskim:mentions | umls-concept:C0041700 | lld:lifeskim |
pubmed-article:20010312 | lifeskim:mentions | umls-concept:C1579319 | lld:lifeskim |
pubmed-article:20010312 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:20010312 | pubmed:dateCreated | 2010-5-6 | lld:pubmed |
pubmed-article:20010312 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20010312 | pubmed:abstractText | Pneumococcal conjugate vaccine (PCV) was introduced in the United Kingdom immunization schedule in September 2006. This study was conducted to establish the immunogenicity of licensed PCV (Prevenar) at a reduced, 2 priming dose schedule (2+1) and to evaluate functional responses in the context of vaccine effectiveness. | lld:pubmed |
pubmed-article:20010312 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20010312 | pubmed:language | eng | lld:pubmed |
pubmed-article:20010312 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20010312 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20010312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20010312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20010312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20010312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20010312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20010312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20010312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20010312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20010312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20010312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20010312 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20010312 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20010312 | pubmed:month | May | lld:pubmed |
pubmed-article:20010312 | pubmed:issn | 1532-0987 | lld:pubmed |
pubmed-article:20010312 | pubmed:author | pubmed-author:GoldblattDavi... | lld:pubmed |
pubmed-article:20010312 | pubmed:author | pubmed-author:MillerElizabe... | lld:pubmed |
pubmed-article:20010312 | pubmed:author | pubmed-author:AndrewsNickN | lld:pubmed |
pubmed-article:20010312 | pubmed:author | pubmed-author:SouthernJoJ | lld:pubmed |
pubmed-article:20010312 | pubmed:author | pubmed-author:AshtonLindsey... | lld:pubmed |
pubmed-article:20010312 | pubmed:author | pubmed-author:WaightPauline... | lld:pubmed |
pubmed-article:20010312 | pubmed:author | pubmed-author:BurbidgePolly... | lld:pubmed |
pubmed-article:20010312 | pubmed:author | pubmed-author:WoodgateSarah... | lld:pubmed |
pubmed-article:20010312 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20010312 | pubmed:volume | 29 | lld:pubmed |
pubmed-article:20010312 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20010312 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20010312 | pubmed:pagination | 401-5 | lld:pubmed |
pubmed-article:20010312 | pubmed:meshHeading | pubmed-meshheading:20010312... | lld:pubmed |
pubmed-article:20010312 | pubmed:meshHeading | pubmed-meshheading:20010312... | lld:pubmed |
pubmed-article:20010312 | pubmed:meshHeading | pubmed-meshheading:20010312... | lld:pubmed |
pubmed-article:20010312 | pubmed:meshHeading | pubmed-meshheading:20010312... | lld:pubmed |
pubmed-article:20010312 | pubmed:meshHeading | pubmed-meshheading:20010312... | lld:pubmed |
pubmed-article:20010312 | pubmed:meshHeading | pubmed-meshheading:20010312... | lld:pubmed |
pubmed-article:20010312 | pubmed:meshHeading | pubmed-meshheading:20010312... | lld:pubmed |
pubmed-article:20010312 | pubmed:meshHeading | pubmed-meshheading:20010312... | lld:pubmed |
pubmed-article:20010312 | pubmed:meshHeading | pubmed-meshheading:20010312... | lld:pubmed |
pubmed-article:20010312 | pubmed:meshHeading | pubmed-meshheading:20010312... | lld:pubmed |
pubmed-article:20010312 | pubmed:meshHeading | pubmed-meshheading:20010312... | lld:pubmed |
pubmed-article:20010312 | pubmed:meshHeading | pubmed-meshheading:20010312... | lld:pubmed |
pubmed-article:20010312 | pubmed:meshHeading | pubmed-meshheading:20010312... | lld:pubmed |
pubmed-article:20010312 | pubmed:meshHeading | pubmed-meshheading:20010312... | lld:pubmed |
pubmed-article:20010312 | pubmed:meshHeading | pubmed-meshheading:20010312... | lld:pubmed |
pubmed-article:20010312 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20010312 | pubmed:articleTitle | Immunogenicity of a reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the United Kingdom. | lld:pubmed |
pubmed-article:20010312 | pubmed:affiliation | Immunobiology Unit, UCL Institute of Child Health, London, United Kingdom. d.goldblatt@ich.ucl.ac.uk | lld:pubmed |
pubmed-article:20010312 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20010312 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:20010312 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20010312 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20010312 | lld:pubmed |